Loading market dashboard
HLS Therapeutics Inc.
HLTRFHealthcareOTCCA
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
HLS Therapeutics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $94.40M | $92.71M - $97.22M | $28.86M | $0.37 | 1 |
| Dec 2029 | $84.10M | $82.60M - $86.61M | $25.71M | $0.24 | 2 |
| Dec 2028 | $77.20M | $75.82M - $79.51M | $23.60M | $0.07 | 1 |
| Dec 2027 | $64.31M | $62.64M - $67.30M | $19.66M | -$0.03 | 3 |
| Dec 2026 | $58.05M | $57.54M - $58.73M | $17.75M | -$0.27 | 4 |
| Dec 2025 | $55.11M | $54.44M - $55.74M | $16.85M | -$0.39 | 3 |
| Dec 2024 | $56.76M | $56.50M - $57.00M | $17.35M | -$0.61 | 5 |
| Dec 2023 | $63.17M | $62.29M - $63.89M | $20.78M | -$0.717 | 2 |
| Dec 2022 | $62.86M | $61.94M - $63.73M | $20.68M | -$0.635 | 1 |
| Dec 2021 | $60.63M | $59.75M - $61.47M | $19.94M | -$0.377 | 2 |
| Dec 2020 | $55.37M | $54.56M - $56.13M | $18.21M | -$0.36 | 2 |
| Dec 2019 | $54.00M | $53.21M - $54.74M | $17.76M | -$0.343 | 1 |